During the past decade, UC San Diego Moores Cancer Center - Investigational Drug Services conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UC San Diego Moores Cancer Center - Investigational Drug Services" #1 collaborator was "Celgene" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UC San Diego Moores Cancer Center - Investigational Drug Services" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "ALK-positive Advanced NSCLC" (1 trials), "Acute Myeloid Leukemia" (1 trials), "Carcinoma, Renal Cell" (1 trials) and "Carcinoma, Squamous Cell of Head and Neck" (1 trials). Many other conditions were trialed in "UC San Diego Moores Cancer Center - Investigational Drug Services" in a lesser frequency.

Most popular intervention types in "UC San Diego Moores Cancer Center - Investigational Drug Services" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Alclometasone cream" (1 trials), "Axitinib" (1 trials), "Binimetinib" (1 trials), "Crizotinib" (1 trials) and "Cytarabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "UC San Diego Moores Cancer Center - Investigational Drug Services" are 7 trials for "All" genders.

Currently, there are NaN active trials in "UC San Diego Moores Cancer Center - Investigational Drug Services". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in UC San Diego Moores Cancer Center - Investigational Drug Services, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UC San Diego Moores Cancer Center - Investigational Drug Services, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".